-
1 Comment
XOMA Corporation is currently in a long term downtrend where the price is trading 0.9% below its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 12.8.
XOMA Corporation's total revenue rose by 6435.5% to $28M since the same quarter in the previous year.
Its net income has increased by 624.6% to $23M since the same quarter in the previous year.
Finally, its free cash flow grew by 497.3% to $16M since the same quarter in the previous year.
Based on the above factors, XOMA Corporation gets an overall score of 4/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| Industry | Biotechnology |
| ISIN | US98419J2069 |
| Sector | Healthcare |
| Beta | 0.57 |
|---|---|
| PE Ratio | None |
| Target Price | 44.67 |
| Dividend Yield | 0.0% |
| Market Cap | 281M |
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for X0M1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
